Tissue microarray technology in the routine assessment of HER2 status in invasive breast cancer
- PMID: 19635107
- DOI: 10.1111/j.1365-2559.2009.03304.x
Tissue microarray technology in the routine assessment of HER2 status in invasive breast cancer
Comment on
-
Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.Histopathology. 2008 Jun;52(7):847-55. doi: 10.1111/j.1365-2559.2008.03047.x. Histopathology. 2008. PMID: 18494613
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
